Successful immunization with a single injection of non-integrating lentiviral vector

Molecular Therapy

Volumn 15, Issue 9, 2007, Pages 1716-1723

  Negri, Donatella R M ^a   Michelini, Zuleika ^a   Baroncelli, Silvia ^a   Spada, Massimo ^a   Vendetti, Silvia ^a   Buffa, Viviana ^b   Bona, Roberta ^a   Leone, Pasqualina ^a   Klotman, Mary E ^c   Cara, Andrea ^a  

^a ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^b ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

^c MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHROMIUM; GAMMA INTERFERON; HUMAN IMMUNODEFICIENCY VIRUS VACCINE; INTEGRASE; LENTIVIRUS VECTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY DETECTION; ARTICLE; BONE MARROW CELL; CODON; CONTROLLED STUDY; DRUG DOSE COMPARISON; DRUG MEGADOSE; ENZYME LINKED IMMUNOSPOT ASSAY; GENE SEQUENCE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMORAL IMMUNITY; IMMUNE RESPONSE; IMMUNIZATION; LOW DRUG DOSE; MOUSE; NONHUMAN; PROTEIN DETERMINATION; SAFETY; SEQUENCE ANALYSIS; SINGLE DRUG DOSE; SPLEEN CELL; VIRAL GENE DELIVERY SYSTEM; VIRAL GENE THERAPY; VIRUS DNA CELL DNA INTERACTION;

ANIMALS; ANTIBODY FORMATION; BONE MARROW CELLS; DEFECTIVE VIRUSES; ENZYME-LINKED IMMUNOSORBENT ASSAY; GENETIC VECTORS; HIV ENVELOPE PROTEIN GP120; HUMANS; IMMUNITY, CELLULAR; IMMUNIZATION; INJECTIONS, INTRAMUSCULAR; INTEGRASES; LENTIVIRUS; MICE; TIME FACTORS;

HUMAN IMMUNODEFICIENCY VIRUS 1; MUS;

EID: 34548108611     PISSN: 15250016     EISSN: 15250024     Source Type: Journal    
DOI: 10.1038/sj.mt.6300241     Document Type: Article

References (50)

1. WHO (2006). The world health report 2006: Working together for health. World Health Organization: Geneva (http://www.who.int/whr/2006/ whro6_en.pdf).
2. Amara, RR, Villinger, F, Altman, JD, Lydy, SL, O'Neil, Sp, Staprans, Sl et al. (2001). Control of a mucosal challenge and prevention of AIDS by a multiprotein DNA/MVA vaccine. Science 292: 69-74.
3. Barouch, DH, Santra, S, Schmitz, JE, Kuroda, MJ, Fu, TM, Wagner W et al. (2000). Control of viremia and prevention of clinical AIDS in rhesus monkeys by cytokine-augmented DNA vaccination. Science 290: 486-492.
4. + T cell response to the HIV-env V3 loop epitope from multiple virus isolates by a DNA prime/vaccinia virus boost (rWR and rMVA strains) immunization regime and enhancement by the cytokine IFN-γ. Virus Res 105: 11-22.
5. Negri, DR, Baroncelli, S, Catone, S, Comini, A, Michelini, Z, Maggiorella, MT et al. (2004). Protective efficacy of a multicomponent vector vaccine in cynomolgus monkeys after intrarectal simian immunodeficiency virus challenge. J Gen Virol 5 1191-1201.
6. Shiver, JW, Fu, TM, Chen, L, Casimiro, DR, Davies, ME, Evans, RK et al. (2002). Replication-incompetent adenoviral vaccine vector elicits effective anti-immunodeficiency-virus immunity. Nature 415: 331-335.
7. Someya, K, Xin, KQ, Matsuo, K, Okuda, K, Yamamoto, N and Honda, M (2004). A consecutive priming-boosting vaccination of mice with simian immunodeficiency virus (SIV) gag/pol DNA and recombinant vaccinia virus strain Dls elicits effective anti-SIV immunity. J Virol 78: 9842-9853.
8. Vanniasinkam, T and Ertl, HC (2005). Adenoviral gene delivery for HIV-1 vaccination. Curr Gene Ther 5: 203-212.
9. Seaman, MS, Xu, L, Beaudry, K, Martin, KL, Beddall, MH, Miura, A et al. (2005). Multiclade human immunodeficiency virus type 1 envelope immunogens elicit broad cellular and humoral immunity in rhesus monkeys. J Virol 79: 2956-2963.
10. Whitney, JB and Ruprecht, RM (2004). Live attenuated HIV vaccines: pitfalls and prospects. Curr Opin Infect Dis 17: 17-26.
11. Koff, WC, Johnson, PR, Watkins, DI, Burton, DR, Lifson, JD, Hasenkrug, KJ et al. (2006). HIV vaccine design: Insights from live attenuated SIV vaccines. Nat Immunol 7: 19-23.
12. Baba, TW, Liska, V, Khimani, AH, Ray, NB, Dailey, PJ, Penninck, D et al. (1999). Live attenuated, multiply deleted simian immunodeficiency virus causes AIDS in infant and adult macaques. Nat Med 5: 194-203.
13. Gundlach, BR, Lewis, MG, Sopper, S, Schnell, T, Sodroski, J, Stahl-Hennig, C et al. (2000). Evidence for recombination of live, attenuated immunodeficiency virus vaccine with challenge virus to a more virulent strain. J Virol 74: 3537-3542.
14. Kafri, T, Blomer, U, Peterson, DA, Gage, FH and Verma, IM (1997). Sustained expression of genes delivered directly into liver and muscle by lentiviral vectors. Nat Genet 17: 314-317.
15. McIver, SR, Lee, CS, Lee, JM, Green, SH, Sands, MS, Snider, BJ et al. (2005). Lentiviral transduction of murine oligodendrocytes in vivo. J Neurosci Res 82: 397-403.
16. Buffa, V, Negri, DRM, Leone, F, Bona, R, Borghi, M, Bacigalupo, I et al. (2006). A single administration of lentiviral vectors expressing either full-length human immunodeficiency virus 1 (HIV-1)(HXB2) Rev/Env or codon-optimized HIV-1 (JR-FL) gp 120 generates durable immune responses in mice. J Gen Virol 87: 1625-1634.
17. Buffa, V, Negri, DR, Leone, P, Borghi, M, Bona, R, Michelini, Z et al. (2006). Evaluation of a self-inactivating lentiviral vector expressing simian immunodeficiency virus gag for induction of specific immune responses in vitro and in vivo. Viral Immunol 19 690-701.
18. Hacein-Bey-Abina, S, Von Kalle, C, Schmidt, M, McCormack, MP, Wulffraat, N, Leboulch, P et al. (2003). LMO2-associated clonal T cell proliferation in two patients after gene therapy for SCID-X1. Science 302: 415-419.
19. Couzin, J and Kaiser, J (2005). As Gelsinger case ends, gene therapy suffers another blow. Science 307: 1028.
20. Coffin, JM, Hughes, SH and Varmus, HE (1997). Retroviruses. Cold Spring Harbor Laboratory Press: Plainview, NY.
21. Cara, A and Klotman, ME (2006). Retroviral E-DNA: Persistence and gene expression in nondividing immune cells. J Leukoc Biol 80: 1013-1017.
22. Vargas, J Jr., Gusella, GL, Najfeld, V, Klotman, ME and Cara, A (2004). Novel integrase-defective lentiviral episomal vectors for gene transfer. Hum Gene Ther 15: 361-372.
23. Nightingale, SJ, Hollis, RP, Pepper, KA, Petersen, D, Yu, XJ, Yang, C et al. (2006). Transient gene expression by nonintegrating lentiviral vectors. Mol Ther 13: 1121-1132.
24. Saenz, DT, Loewen, N, Peretz, M, Whitwam, T, Barraza, R, Howell, KG et al. (2004). Unintegrated lentivirus DNA persistence and accessibility to expression in nondividing cells: Analysis with class 1 integrase mutants. J Virol 78: 2906-2920.
25. Lu, R, Nakajima, N, Hofmann, W, Benkirane, M, Jeang, KT, Sodroski, J et al. (2004). Simian virus 40-based replication of catalytically inactive human immunodeficiency virus type 1 integrase mutants in nonpermissive T cells and monocyte-derived macrophages. J Virol 78: 658-668.
26. Yanez-Munoz, RJ, Balaggan, KS, MacNeil, A, Howe, SJ, Schmidt, M, Smith, AJ et al. (2006). Effective gene therapy with nonintegrating lentiviral vectors. Nat Med 12: 348-353.
27. Philippe, S, Sarkis, C, Barkats, M, Mammeri, H, Ladroue, C, Petit, C et al. (2006). Lentiviral vectors with a defective integrase allow efficient and sustained transgene expression in vitro and in vivo. Proc Natl Acad Sci USA 103: 17684-17689.
28. Zufferey, R, Dull, T, Mandel, RJ, Bukovsky, A, Quiroz, D, Naldini, L et al. (1998). Self-inactivating lentivirus vector for safe and efficient in vivo gene delivery. J Virol 72:9873-9880.
29. Loewen, N and Poeschla, EM (2005). Lentiviral vectors. Adv Biochem Eng Biotechnol 99: 169-191.
30. Gillim-Ross, L, Cara, A and Klotman, ME (2005). HIV-1 extrachromosomal 2-LTR circular DNA is long-lived in human macrophages. Viral Immunol 18: 190-196.
31. Moore, AC, Kong, Wp, Chakrabarti, BK and Nabel, GJ (2002). Effects of antigen and genetic adjuvants on immune responses to human immunodeficiency virus DNA vaccines in mice.J Virol 76: 243-250.
32. Di Rosa, F and Pabst, R (2005). The bone marrow: A nest for migratory memory T cells. Trends Immunol 26: 360-366.
33. Parretta, E, Cassese, G, Barba, P, Santoni, A, Guardiola, J and Di Rosa, F (2005). CD8 cell division maintaining cytotoxic memory occurs predominantly in the bone marrow. J Immunol 174: 7654-7664.
34. Andre, S, Seed, B, Eberle, J, Schraut, W, Bultmann, A and Haas, J (1998). Increased immune response elicited by DNA vaccination with a synthetic gpl 20 sequence with optimized codon usage. J Virol 72: 1497-1503.
35. Taddeo, B, Haseltine, WA and Farnet, CM (1994). Integrase mutants of human immunodeficiency virus type 1 with a specific defect in integration. J Virol 68:8401-8405.
36. Cara, A, Guarnaccia, F, Reitz, MS, Gallo, RC and Lori, F (1995). Self-limiting, cell type-dependent replication of an integrase defective human immunodeficiency virus type 1 in primary macrophages but not lymphocytes. Virology 208: 242-248.
37. Leavitt, AD, Robles, G, Alesandro, N and Varmus, HE (1996). [Human immunodeficiency virus type 1 integrase mutants retain in vitro integrase activity yet fail to integrate viral DNA efficiently during infection. J Virol 70: 721-728.
38. Nakajima, N, Lu, R and Engelman, A (2001). Human immunodeficiency virus type 1 replication in the absence of integrase-mediated DNA recombination: Definition of permissive and nonpermissive T-cell lines.J Virol 75: 7944-7955.
39. Poon, B and Chen, IS (2003). Human immunodeficiency virus type 1 (HIV-1) Vpr enhances expression from unintegrated HIV-1 DNA. J Virol 77 3962-3972.
40. Wu, Y and Marsh, JW (2003). Early transcription from nonintegrated DNA in human immunodeficiency virus infection. J Virol 77: 10376-10382.
41. Tan, W, Dong, Z, Wilkinson, TA, Barbas, CF 3rd and Chow, SA (2006). Human immunodeficiency virus type 1 incorporated with fusion proteins consisting of integrase and the designed polydactyl zinc finger protein E2C can bias integration of viral DNA into a predetermined chromosomal region in human cells. J Virol 80: 1939-1948.
42. Naldini, L, Blomer, U, Gallay, P, Ory, D, Mulligan, R, Gage, FH et al. (1996). In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector. Science 272: 263-267.
43. Bona, R, Andreotti, M, Buffa, V, Leone, P, Galluzzo, CM, Amici, R et al. (2006). Development of a human immunodeficiency virus vector-based, single-cycle assay for evaluation of anti-integrase compounds. Antimicrob Agents Chemother 50: 3407-3417.
44. Weiss, R, Teich, N, Varmus, H and Coffin, J (1992). RNA tumor viruses, 2nd edn. Cold Spring Harbor Laboratory Press: Cold Spring Harbor, NY. pp. 1205-1218.
45. Alexander-Miller, MA, Parker, KC, Tsukui, T, Pendleton, CD, Coligan, JE and Berzofsky, JA (1996). Molecular analysis of presentation by HLA-A2.1 of a promiscuously binding V3 loop peptide from the HIV-envelope protein to human cytotoxic T lymphocytes. Int Immunol 8: 641-649.
46. Gambotto, A, Dworacki, G, Cicinnati, V, Kenniston, T, Steitz, J, Tuting, T et al. (2000). Immunogenicity of enhanced green fluorescent protein (EGFP) in BALB/c mice: Identification of an H 2-Kd -restricted CTL epitope. Gene Ther 7: 2036-2040.
47. Butto, S, Fiorelli, V. Tripiciano, A, Ruiz-Alvarez, MJ, Scoglio, A, Ensoli, F et al. (2003). Sequence conservation and antibody cross-recognition of clade B human immunodeficiency virus (HIV) type 1 Tat protein in HIV-1 -infected Italians, Ugandans, and South Africans. J Infect Dis 188: 1171-1180.
48. Otto, P, Kephart, D, Bitner, R, Huber, S and Volkerding, K (1998). Separate isolation of genomic DNA and total RNA from single samples using the SV total RNA isolation system. Promega Notes 69: 19-24.
49. Di Natale, F, Di Domenico, C, Gargiulo, N, Castaldo, S, Gonzalez, Y. Reyero, E et al. (2005). Treatment of the mouse model of mucopolysaccharidosis type IIIB with lentiviral-NAGLU vector. Biochem J 388: 639-646.
50. Jurka, J, Kohany. O, Pavlicek, A, Kapitonov, VV and Jurka, MV (2005). Clustering, duplication and chromosomal distribution of mouse SINE retrotransposons. Cytogenet Genome Res 110: 117-123.